Skip to main content

Table 2 Demographic data and patient characteristics

From: Association of periprocedural phentolamine infusion with favorable outcome in patients with chronic kidney disease and chronic coronary syndrome undergoing coronary catheterization: a prospective randomized controlled pilot study

 

Group 1 (N = 52)

Group 2 (N = 55)

P value

Mean ± SD

Mean ± SD

Age (Years)

58.5 ± 7.83

58.73 ± 10.03

0.914

Baseline Serum Creatinine

1.65 ± 0.58

1.82 ± 0.39

0.847

Baseline eGFR

44.58 ± 10.06

38.41 ± 9.81

0.002

Ejection Fraction

54.17 ± 11.64

51.67 ± 10.46

0.233

 

Group 1 (N = 52)

Group 2 (N = 55)

P value

N

%

N

%

Male

17

32.7%

21

38.2%

0.553

Female

35

67.3%

34

61.8%

Mild CKD

31

59.6%

15

27.3%

0.003

Moderate CKD

17

32.7%

30

54.5%

Severe CKD

4

7.7%

10

18.2%

Hypertension

42

80.8%

47

85.5%

0.517

Smoking

33

63.5%

31

56.4%

0.454

CABG History

2

3.8%

4

7.3%

0.679

CHF

31

59.6%

28

50.9%

0.365

STEMI

34

65.4%

44

80.0%

0.250

NSTEMI

12

23.1%

7

12.7%

UA

6

11.5%

4

7.3%

Old PCI once

12

23.1%

11

20.0%

0.703

Old PCI Twice

1

1.9%

3

5.5%

Old CA once

24

46.2%%

27

49.1%

0.733

Old CA Twice

0

0.0%

1

1.8%

  1. CHF Congestive Heart Failure, CA Coronary Angiography, CABG Coronary Artery Bypass Graft, PCI Percutaneous coronary intervention, NSTEMI Non-ST segment myocardial infarction, STEMI ST segment elevation myocardial infarction, UA Unstable angina